INSIGHTS ON CLINICAL TRIAL DESIGN

CLINICAL TRIAL DESIGN SOLUTIONS

  • A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.

  • Traditional clinical trial models can create financial burden by neglecting participant needs – but effective use of stipends can allow participants to fully engage without financial worries.

  • Psychiatric trials have long been among the most difficult to enroll. From treatment-resistant depression (TRD) and PTSD to cognitive and neuro disorders, sponsors are facing the same challenges over and over again:

    • Narrow I/E criteria that don’t translate into real-world patients
    • Sites with limited behavioral health infrastructure
    • Lack of patient trust and trial awareness in psychiatric populations
    • Professional patients
    • Rating scales aren’t used in clinical practices

    But what if recruitment didn’t have to start with a gamble?

  • Enable consistent protocol execution with standardized workflows for training, monitoring, documentation, inventory, and drug accountability.

  • The window for identifying the right patients to enroll in clinical trials is shrinking. With Citeline PatientMatch, sponsors can pinpoint eligible patients before a treatment plan is finalized.